IRIS
FROECHLICH, GUENDALINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 195
NA - Nord America 191
AS - Asia 16
AF - Africa 10
SA - Sud America 2
Totale 414
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 191
IT - Italia 123
GB - Regno Unito 38
NL - Olanda 24
CI - Costa d'Avorio 10
CN - Cina 8
IN - India 7
SE - Svezia 5
BR - Brasile 2
FI - Finlandia 2
ES - Italia 1
PL - Polonia 1
RS - Serbia 1
SG - Singapore 1
Totale 414
Salva come PNG Salva come JPEG
Città #
Naples 52
Chandler 45
Ashburn 26
Amsterdam 24
Millbury 13
Lawrence 11
Napoli 11
Marano 7
Pune 7
Des Moines 5
Boston 4
Formia 4
Wilmington 4
Arezzo 3
Beijing 3
Los Angeles 3
San Vitaliano 3
Seattle 3
Trentola-Ducenta 3
Washington 3
Ischia 2
Lappeenranta 2
Marano di Napoli 2
Nanjing 2
Reggio Emilia 2
São Paulo 2
Acerra 1
Aprilia 1
Augusta 1
Belgrade 1
Casavatore 1
Fairfield 1
Fisciano 1
Gdansk 1
Hebei 1
Jiaxing 1
Marcianise 1
Misterbianco 1
Norwalk 1
Philadelphia 1
Princeton 1
Rome 1
Salerno 1
San Giuseppe Vesuviano 1
Selargius 1
Shanghai 1
Silea 1
Totale 267
Salva come PNG Salva come JPEG
Nome #
Integrity of the antiviral STING-mediated DNA sensing in tumor cells is required to sustain the immunotherapeutic efficacy of herpes simplex oncolytic virus 68
Generation of a novel mesothelin-targeted oncolytic herpes virus and implemented strategies for manufacturing 63
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. 37
Generation of a retargeted oncolytic herpes virus encoding adenosine deaminase for tumor adenosine clearance 37
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells 34
A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells 33
Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis 30
Novel combinations of human immunomodulatory mAbs lacking cardiotoxic effects for therapy of TNBC 30
Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment 28
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand 23
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling 22
Immunomodulatory mabs as tools to investigate on cis-interaction of pd-1/pd-l1 on tumor cells and to set up methods for early screening of safe and potent combinatorial treatments 18
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC 17
The common H232 STING allele shows impaired activities in DNA sensing, susceptibility to viral infection, and in monocyte cell function, while the HAQ variant possesses wild-type properties 8
Prime and pull of Tcell responses against cancer-exogenous antigens is effective against CPI-resistant tumors 1
Totale 449
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.759
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 4 0 1 1 1 0 0 0 0 1 2 0
2020/202117 0 0 4 0 0 0 0 5 0 4 4 0
2021/2022141 2 3 10 4 7 7 26 10 16 15 18 23
2022/2023131 12 6 2 6 23 16 1 10 20 25 10 0
2023/2024139 4 16 26 18 7 24 1 14 2 24 3 0
Totale 449